ErbB3 predominantly forms a heterodimer with ErbB2 and was found to be critically involved in tumour initiation and progression and is now considered one of the most active signalling dimers of the ErbB family in cancer [98,99,100]. This evidence concerns the gene ERBB3 and neoplasm.